Used primarily in pharmaceutical research as a selective estrogen receptor modulator (SERM). It shows potential in treating hormone-related conditions such as breast cancer and osteoporosis due to its ability to mimic or block estrogen in specific tissues. Its structure allows for high affinity to estrogen receptors with tissue-specific activity, making it a candidate for targeted therapies. Also investigated for improving lipid metabolism and cardiovascular health without stimulating uterine tissue. Currently under study in preclinical models for efficacy and safety.